Matches in Wikidata for { <http://www.wikidata.org/entity/Q87078161> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q87078161 description "clinical trial" @default.
- Q87078161 description "ensayu clínicu" @default.
- Q87078161 description "klinisch onderzoek" @default.
- Q87078161 description "клінічне випробування" @default.
- Q87078161 name "Safety Study of BJ-001, and IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors" @default.
- Q87078161 name "Safety Study of BJ-001, and IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors" @default.
- Q87078161 type Item @default.
- Q87078161 label "Safety Study of BJ-001, and IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors" @default.
- Q87078161 label "Safety Study of BJ-001, and IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors" @default.
- Q87078161 prefLabel "Safety Study of BJ-001, and IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors" @default.
- Q87078161 prefLabel "Safety Study of BJ-001, and IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors" @default.
- Q87078161 P1132 Q87078161-286131E6-554C-4BF8-84F5-70CAABED4390 @default.
- Q87078161 P1476 Q87078161-E58F8B07-049C-417D-89C8-2D01D458FF2F @default.
- Q87078161 P17 Q87078161-DF6E03E9-A9B6-4749-BF94-EA480DD7C35F @default.
- Q87078161 P1813 Q87078161-1E3ECA7F-0A39-4F4E-A5E0-1612D91FE0DF @default.
- Q87078161 P2899 Q87078161-9D4D44E2-56BD-4F53-95A1-65AD5AD9F5F0 @default.
- Q87078161 P3098 Q87078161-80B61E6C-0D16-4B48-9CB4-5126BBB04DA5 @default.
- Q87078161 P31 Q87078161-0CC576C3-D09C-4B3B-BE65-D07D60591D82 @default.
- Q87078161 P4844 Q87078161-6A660833-D1F6-49E5-BC83-EB1BBA84242F @default.
- Q87078161 P580 Q87078161-156EEB67-6989-4194-8282-C5C9B957DF82 @default.
- Q87078161 P582 Q87078161-D719329D-BC35-40E2-9544-3992F1DA1945 @default.
- Q87078161 P6099 Q87078161-0312EC09-752C-40DA-82EA-2C8E8DE170D5 @default.
- Q87078161 P8363 Q87078161-7F937280-3B91-4D97-8431-EF6F6269F939 @default.
- Q87078161 P921 Q87078161-E1DB4BBC-1002-41F0-B1CA-A278B0E14B82 @default.
- Q87078161 P1132 "+92" @default.
- Q87078161 P1476 "First-in-human (FIH), Open-Label, Phase 1a (Dose Escalation)/Phase 1b (Expansion Cohorts) Trial of BJ-001 as a Single Agent and in Combination With Pembrolizumab (Keytruda) in Patients With Locally Advanced/Metastatic Solid Tumors" @default.
- Q87078161 P17 Q30 @default.
- Q87078161 P1813 "FIH" @default.
- Q87078161 P2899 "+18" @default.
- Q87078161 P3098 "NCT04294576" @default.
- Q87078161 P31 Q30612 @default.
- Q87078161 P4844 Q13896859 @default.
- Q87078161 P580 "2019-12-04T00:00:00Z" @default.
- Q87078161 P582 "2022-04-29T00:00:00Z" @default.
- Q87078161 P6099 Q5452194 @default.
- Q87078161 P8363 Q78089383 @default.
- Q87078161 P921 Q55950233 @default.